126 related articles for article (PubMed ID: 7932243)
21. Assessment of p63 expression in oral squamous cell carcinomas and dysplasias.
Bortoluzzi MC; Yurgel LS; Dekker NP; Jordan RC; Regezi JA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Dec; 98(6):698-704. PubMed ID: 15583543
[TBL] [Abstract][Full Text] [Related]
22. Assessment of proliferating cell nuclear antigen (PCNA) expression at the invading front of oral squamous cell carcinoma.
Lu EM; Ratnayake J; Rich AM
BMC Oral Health; 2019 Oct; 19(1):233. PubMed ID: 31672124
[TBL] [Abstract][Full Text] [Related]
23. Expression profile of apoptotic mediators and proliferative markers in oral squamous cell carcinoma.
Ahmed MM
J Egypt Natl Canc Inst; 2009 Jun; 21(2):85-92. PubMed ID: 21057559
[TBL] [Abstract][Full Text] [Related]
24. Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma.
Georgescu CV; Săftoiu A; Georgescu CC; Ciurea R; Ciurea T
J Gastrointestin Liver Dis; 2007 Jun; 16(2):133-9. PubMed ID: 17592558
[TBL] [Abstract][Full Text] [Related]
25. Basaloid squamous carcinoma of the oral cavity: report of 2 cases and study of AgNOR, PCNA, p53, and MMP expression.
Coletta RD; Cotrim P; Vargas PA; Villalba H; Pires FR; de Moraes M; de Almeida OP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):563-9. PubMed ID: 11346736
[TBL] [Abstract][Full Text] [Related]
26. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma.
Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Tomoyose T; Takano H; Funaki K; Fukuyama H; Takahashi T; Sakoda S
J Oral Pathol Med; 2005 Nov; 34(10):602-7. PubMed ID: 16202080
[TBL] [Abstract][Full Text] [Related]
27. p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma.
Hirvikoski P; Kumpulainen E; Virtaniemi J; Johansson R; Haapasalo H; Marin S; Halonen P; Helin H; Raitiola H; Pukander J; Kellokumpu-Lehtinen P; Kosma VM
J Clin Oncol; 1997 Sep; 15(9):3111-20. PubMed ID: 9294474
[TBL] [Abstract][Full Text] [Related]
28. Correlation of the standardized uptake value in FDG-PET with the expression level of cell-cycle-related molecular biomarkers in resected non-small cell lung cancers.
Nakamura H; Hirata T; Kitamura H; Nishikawa J
Ann Thorac Cardiovasc Surg; 2009 Oct; 15(5):304-10. PubMed ID: 19901884
[TBL] [Abstract][Full Text] [Related]
29. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
[TBL] [Abstract][Full Text] [Related]
31. [Immunohistochemical expression of p53 protein in squamous epithelial carcinomas and normal and dysplastic epithelium of the mouth cavity].
Piffkó J; Bánkfalvi A
Mund Kiefer Gesichtschir; 1997 Mar; 1(2):104-7. PubMed ID: 9410611
[TBL] [Abstract][Full Text] [Related]
32. Expression of p53 in human esophageal carcinoma: an immunohistochemical study with correlation to proliferating cell nuclear antigen expression.
Sasano H; Miyazaki S; Gooukon Y; Nishihira T; Sawai T; Nagura H
Hum Pathol; 1992 Nov; 23(11):1238-43. PubMed ID: 1358781
[TBL] [Abstract][Full Text] [Related]
33. Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival.
Soini Y; Virkajärvi N; Lehto VP; Pääkkö P
Br J Cancer; 1996 May; 73(9):1025-30. PubMed ID: 8624258
[TBL] [Abstract][Full Text] [Related]
34. The presence of p53 protein in relation to Ki-67 as cellular proliferation marker in head and neck squamous cell carcinoma and adjacent dysplastic mucosa.
Slootweg PJ; Koole R; Hordijk GJ
Eur J Cancer B Oral Oncol; 1994; 30B(2):138-41. PubMed ID: 8032302
[TBL] [Abstract][Full Text] [Related]
35. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P
Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical detection of p53 protein in preneoplastic lesions and squamous cell carcinoma of the head and neck.
Lavieille JP; Brambilla E; Riva-Lavieille C; Reyt E; Charachon R; Brambilla C
Acta Otolaryngol; 1995 Mar; 115(2):334-9. PubMed ID: 7610836
[TBL] [Abstract][Full Text] [Related]
37. Multiparameter flow cytometry for simultaneous assessment of p53 protein expression and cellular DNA content in oral squamous cell carcinomas: evidence for the development of aneuploid clones from p53-deficient diploid progenitor cells.
Hemmer J; Polackova J
Int J Oncol; 2000 Nov; 17(5):933-7. PubMed ID: 11029495
[TBL] [Abstract][Full Text] [Related]
38. [Value of the proliferation status (PCNA) and p53 immunohistochemistry as a prognostic factor for the clinical course of superficial cancer of the urinary bladder].
Kuczyk MA; Serth J; Bokemeyer C; Hervatin C; Oelke M; Oelert F; Höfner K; Jonas U
Urologe A; 1995 Mar; 34(2):146-52. PubMed ID: 7754587
[TBL] [Abstract][Full Text] [Related]
39. p53 expression in oat and non-oat small cell lung carcinomas: correlations with proliferating cell nuclear antigen.
Korkolopoulou P; Oates J; Crocker J; Edwards C
J Clin Pathol; 1993 Dec; 46(12):1093-6. PubMed ID: 7904273
[TBL] [Abstract][Full Text] [Related]
40. Cytogenetic significance of chromosome 17 aberrations and P53 gene mutations as prognostic markers in oral squamous cell carcinoma.
Zedan W; Mourad MI; El-Aziz SM; Salamaa NM; Shalaby AA
Diagn Pathol; 2015 Feb; 10():2. PubMed ID: 25881131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]